Gene therapy for mucopolysaccharidosis

International Review of Neurobiology

Volumn 55, Issue , 2003, Pages 271-296

  Bosch, Assumpció ^a   Heard, Jean Michel ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; GENE THERAPY; HUMAN; METHODOLOGY; MUCOPOLYSACCHARIDOSIS; REVIEW;

ANIMALS; GENE THERAPY; HUMANS; MUCOPOLYSACCHARIDOSES;

EID: 0141818018     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(03)01012-2     Document Type: Article

References (107)

1. Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., Jacobson, S. G., Hauswirth, W. W., and Bennett, J. (2001). Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet. 28, 92-95.
2. Anand, V., Duffy, B., Yang, Z., Dejneka, N. S., Maguire, A. M., and Bennett, J. (2002). A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus. Mol. Ther. 5, 125-132.
3. Anson, D. S., Bielicki, J., and Hopwood, J. J. (1992). Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene. Hum. Gene Ther. 3, 371-379.
4. Aronovich, E. L., Johnston, J. M., Wang, P., Giger, U., and Whitley, C. B. (2001). Molecular basis of mucopolysaccharidosis type III B in emu (Dromaius novaenollandiae): an avian model of Sanfilippo syndrome type B. Genomics 74, 299-305.
5. Ashton, L. J., Brooks, D. A., McCourt, P. A., Muller, V. J., Clements, P. R., and Hopwood, J. J. (1992). Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients. Am. J. Hum. Genet. 50, 787-794.
6. Bachoud-Levi, A. C., Deglon, N., Nguyen, J. P., Bloch, J., Bourdet, C., Winkel, L., Remy, P., Goddard, M., Lefaucheur, J. P., Brugieres, P., Baudic, S., Cesaro, P., Peschanski, M., and Aebischer, P. (2000). Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum. Gene Ther. 11, 1723-1729.
7. Barton, N. W., Brady, R. O., Dambrosia, J. M., Di Bisceglie, A. M., Doppelt, S. H., Hill, S. C., Mankin, H. J., Murray, G. J., Parker, R. I., Argoff, C. E., et al. (1991). Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease. N. Engl. J. Med. 324, 1464-1470.
8. Bastedo, L., Sands, M. S., Lambert, D. T., Pisa, M. A., Birkenmeier, E., and Chang, P. L. (1994). Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII. J. Clin. Invest. 94, 1180-1186.
9. Bhaumik, M., Muller, V. J., Rozaldis, T., Johnson, L., Dobrenis, K., Bhattacharyya, R., Wurzelmann, S., Finamore, P., Hopwood, J. J., Walkley, S. U., and Stanley, P. (1999). A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome). Glycobioloiy 9, 1389-1396.
10. Birkenmeier, E. H. (1991). Correction of murine mucopolysaccharidosis type VII (MPS VII) by bone marrow transplantation and gene transfer therapy. Hum. Gene Ther. 2, 113.
11. Birkenmeier, E. H., Davisson, M. T., Beamer, W. G., Ganschow, R. E., Vogler, C. A., Gwynn, B., Lyford, K. A., Maltais, L. M., and Wawrzyniak, G. J. (1989). Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. J. Clin. Invest. 83, 1258-1266.
12. Bosch, A., Perret, E., Desmaris, N., and Heard, J. M. (2000a). Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors. Mol. Ther. 1, 63-70.
13. Bosch, A., Perret, E., Desmaris, N., Trono, D., and Heard, J. M. (2000b). Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. Hum. Gene Ther. 11, 1139-1150.
14. Brooks, A. I., Stein, C. S., Hughes, S. M., Heth, J., McCray, P. M., Jr., Sauter, S. L., Johnston, J. C., Cory-Slechta, D. A., Federoff, H. J., and Davidson, B. L. (2002). Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc. Natl. Acad. Sci. USA 99, 6216-6221.
15. Brooks, D. A., McCourt, P. A., Gibson, G. J., Ashton, L. J., Shutter, M., and Hopwood, J. J. (1991). Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients. Am. J. Hum. Genet. 48, 710-719.
16. Brooks, D. A., Hopwood, J. J., and King, B. M. (1998). Immune response to enzyme replacement therapy: Clinical signs of hypersensitivity reactions and altered enzyme distribution in a high titre rat model. Biochim. Biophys. Acta 1407, 163-172.
17. Chen, W., Wu, X., Levasseur, D. N., Liu, H., Lai, L., Kappes, J. C., and Townes, T. M. (2000). Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice. Stem Cells 18, 352-359.
18. Clarke, L. A., Russell, C. S., Pownall, S., Warrington, C. L., Borowski, A., Dimmick, J. E., Toone, J., and Jink, F. R. (1997). Murine mucopolysaccharidosis type I: Targeted disruption of the murine alpha-L-iduronidase gene. Hum. Mol. Genet. 6, 503-511.
19. Daly, T. M., Okuyama, T., Vogler, C., Haskins, M. E., Muzyczka, N., and Sands, M. S. (1999a). Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice. Hum. Gene Ther. 10, 85-94.
20. Daly, T. M., Vogler, C., Levy, B., Haskins, M. E., and Sands, M. S. (1999b). Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc. Natl. Acad. Sci. USA 96, 2296-2300.
21. Daly, T. M., Ohlemiller, K. K., Roberts, M. S., Vogler, C. A., and Sands, M. S. (2001). Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Gene Ther. 8, 1291-1298.
22. Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., and Chiorini, J. A. (2000). Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. USA 97, 3428-3432.
23. Dean, M. F., Muir, H., Benson, P. F., Button, L. R., Boylston, A., and Mowbray, J. (1976). Enzyme replacement therapy by fibroblast transplantation in a case of Hunter syndrome. Nature 261, 323-325.
24. Déglon, N., Heyd, B., Tan, S. A., Joseph, J. M., Zum, A. D., and Aebischer, P. (1996). Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts. Hum. Gent Ther. 7, 2135-2146.
25. Desmaris, N., Bosch, A., Salaün, C., Petit, C., Prevost, M. C., Tordo, N., Perrin, P., Schwartz, O., de Rocquigny, H., and Heard, J. M. (2001). Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Mol. Ther. 4, 149-156.
26. Downs-Kelly, E., Jones, M. Z., Alroy, J., Cavanagh, K. T., King, B., Lucas, R. E., Baker, J. C., Kraemer, S. A., and Hopwood, J. J. (2000). Caprine mucopolysaccharidosis IIID: A preliminary trial of enzyme replacement therapy. J. Mol. Neurosci. 15, 251-262.
27. Elliger, S. S., Eiliger, C. A., Aguilar, C. P., Raju, N. R., and Watson, G. L. (1999). Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adenoassociated virus vector. Gene Ther. 6, 1175-1178.
28. Eng, C. M., Guffon, N., Wilcox, W. R., Germain, D. P., Lee, P., Waldek, S., Caplan, L., Linthorst, G. E., and Desnick, R. J. (2001). Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease. N. Engl. J. Med. 345, 9-16.
29. Evers, M., Saftig, P., Schmidt, P., Hafner, A., McLoghlin, D. B., Schmahl, W., Hess, B., von Figura, K., and Peters, C. (1996). Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI. Proc. Natl. Acad. Sci. USA 93, 8214-8219.
30. Fairbairn, L. J., Lashford, L. S., Spooncer, E., McDermott, R. H., Lebens, G., Arrand, J. E., Arrand, J. R., Bellantuono, I., Holt, R., Hatton, C. E., Cooper, A., Besley, G. T., Wraith, J. E., Anson, D. S., Hopwood, J. J., and Dexter, T. M. (1996). Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow. Proc. Natl. Acad. Sci. USA 93, 2025-2030.
31. Fischer, A., Carmichael, K. P., Munnell, J. F., Jhabvala, P., Thompson, J. N., Matalon, R., Jezyk, P. F., Wang, P., and Giger, U. (1998). Sulfamidase deficiency in a family of Dachshunds: A canine model of mucopolysaccharidosis IIIA (Sanfilippo A). Pediatr. Res. 44, 74-82.
32. Fratantoni, J. C., Hall, C. W., and Neufeld, E. F. (1968). Hurler and Hunter syndromes: Mutual correction of the defect in cultured fibroblasts. Science 162, 570-572.
33. Freeman, B. J., Roberts, M. S., Vogler, C. A., Nicholes, A., Hofling, A. A., and Sands, M. S. (1999). Behavior and therapeutic efficacy of beta-glucuronidase-positive mononuclear phagocytes in a murine model of mucopolysaccharidosis type VII. Blood 94, 2142-2150.
34. Frisella, W. A., O'Connor, L. H., Vogler, C. A., Roberts, M., Walkley, S., Levy, B., Daly, T. M., and Sands, M. S. (2001). Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII. Mol. Ther. 3, 351-358.
35. Fyfe, J. C., Kurzhals, R. L., Lassaline, M. E., Henthorn, P. S., Alur, P. R., Wang, P., Wolfe, J. H., Giger, U., Haskins, M. E., Patterson, D. F., Sun, H., Jain, S., and Yuhki, N. (1999). Molecular basis of feline beta-glucuronidase deficiency: An animal model of mucopolysaccharidosis VII. Genomics 58, 121-128.
36. Ghodsi, A., Stein, C., Derksen, T., Yang, G., Anderson, R. D., and Davidson, B. L. (1998). Extensive beta-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain. Hum. Gene Ther. 9, 2331-2340.
37. Ghodsi, A., Stein, C., Derksen, T., Martins, I., Anderson, R. D., and Davidson, B. L. (1999). Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer. Exp. Neurol. 160, 109-116.
38. Grabowski, G. A., Leslie, N., and Wenstrup, R. (1998). Enzyme therapy for Gaucher disease: The first 5 years. Blood Rev. 12, 115-133.
39. Haskins, M. E., Aguirre, G. D., Jezyk, P. F., Desnick, R. J., and Patterson, D. F. (1983). The pathology of the feline model of mucopolysaccharidosis I. Am. J. Pathol. 112, 27-36.
40. Haskins, M. E., Desnick, R. J., DiFerrante, N., Jezyk, P. F., and Patterson, D. F. (1984). Beta-glucuronidase deficiency in a dog: A model of human mucopolysaccharidosis VII. Pediatr. Res. 18, 980-984.
41. Hoogerbrugge, P. M., Poorthuis, B. J., Mulder, A. H., Wagemaker, G., Dooren, L. J., Vossen, J. M., and van Bekkum, D. W. (1987). Correction of lysosomal enzyme deficiency in various organs of beta-glucuronidase-deficient mice by allogeneic bone marrow transplantation. Transplantation 43, 609-614.
42. Hoogerbrugge, P. M., Brouwer, O. F., Bordigoni, P., Ringden, O., Kapaun, P., Ortega, J. J., O'Meara, A., Cornu, G., Souillet, G., Frappaz, D., et al. (1995). Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation. Lancet 345, 1398-1402.
43. Hughes, S. M., Moussavi-Harami, F., Sauter, S. L., and Davidson, B. L. (2002). Viral-mediated gene transfer to mouse primary neural progenitor cells. Mol. Ther. 5, 16-24.
44. Jezyk, P. F., Haskins, M. E., Patterson, D. F., Mellman, W. J., and Greenstein, M. (1977). Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: A model of Maroteaux-Lamy syndrome. Science 198, 834-836.
45. Kakkis, E. D., McEntee, M. F., Schmidtchen, A., Neufeld, E. F., Ward, D. A., Gompf, R. E., Kania, S., Bedolla, C., Chien, S. L., and Shull, R. M. (1996). Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I. Biochem. Mol. Med. 58, 156-167.
46. Kakkis, E. D., Muenzer, J., Tiller, G. E., Waber, L., Belmont, J., Passage, M., Izykowski, B., Phillips, J., Doroshow, R., Walot, I., Hoft, R., and Neufeld, E. F. (2001a). Enzyme-replacement therapy in mucopolysaccharidosis I. N. Engl. J. Med. 344, 182-188.
47. Kakkis, E. D., Schuchman, E., He, X., Wan, Q., Kania, S., Wiemelt, S., Hasson, C. W, O'Malley, T., Weil, M. A., Aguirre, G. A., Brown, D. E., and Haskins, M. E. (2001b). Enzyme replacement therapy in feline mucopolysaccharidosis I. Mol. Genet. Metab. 72, 199-208.
48. Kamata, Y., Okuyama, T., Kosuga, M., O'Hira, A., Kanaji, A., Sasaki, K., Yamada, M., and Azuma, N. (2001). Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII. Mol. Ther. 4, 307-312.
49. Kaplan, A., Achord, D. T., and Sly, W. S. (1977). Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc. Natl. Acad. Sci. USA 74, 2026-2030.
50. Kosuga, M., Takahashi, S., Sasaki, K., Enosawa, S., Li, X. K., Okuyama, S., Fujino, M., Suzuki, S., Yamada, M., Matsuo, N., Sakuragawa, N., and Okuyama, T. (2000). Phenotype correction in murine mucopolysaccharidosis type VII by transplantation of human amniotic epithelial cells after adenovirus-mediated gene transfer. Cell Transplant 9, 687-692.
51. Kosuga, M., Sasaki, K., Tanabe, A., Li, X. K., Okawa, H., Ogino, L., Okuda, O., Arai, H., Sakuragawa, N., Kamata, Y., Azuma, N., Suzuki, S., Yamada, M., and Okuyama, T. (2001). Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in mucopolysaccharidosis type VII mice. Mol. Ther. 3, 139-148.
52. Krause, D. S., Theise, N. D., Collector, M. I., Henegariu, O., Hwang, S., Gardner, R., Neutzel, S., and Sharkis, S. J. (2001). Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105, 369-377.
53. Krivit, W., Lockman, L. A., Watkins, P. A., Hirsch, J., and Shapiro, E. G. (1995). The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J. Inherit. Metab. Dis. 18, 398-112.
54. Li, H. H., Yu, W. H., Rozengurt, N., Zhao, H. Z., Lyons, K. M., Anagnostaras, S., Fanselow, M. S., Suzuki, K., Vanier, M. T., and Neufeld, E. F. (1999). Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc. Natl. Acad. Sci. USA 96, 14505-14510.
55. Li, T., and Davidson, B. L. (1995). Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA. 92, 7700-7704.
56. Maréchal, V., Naffakh, N., Danos, O., and Heard, J. M. (1993). Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells. Blood 82, 1358-1365.
57. Miana-Mena, F. J., Roux, S., Benichou, J. C., Osta, R., and Brulet, P. (2002). Neuronal activity-dependent membrane traffic at the neuromuscular junction. Proc. Natl. Acad. Sci. USA 99, 3234-3239.
58. Moullier, P., Bohl, D., Heard, J. M., and Danos, O. (1993a). Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat. Genet. 4, 154-159.
59. Moullier, P., Maréchal, V., Danos, O., and Heard, J. M. (1993b). Continuous systemic secretion of a lysosomal enzyme by genetically modified mouse skin fibroblasts. Transplantation 56, 427-132.
60. Moullier, P., Bohl, D., Cardoso, J., Heard, J. M., and Danos, O. (1995). Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs. Nat. Med. 1, 353-357.
61. O'Connor, L. H., Erway, L. C., Vogler, C. A., Sly, W. S., Nicholes, A., Grubb, J., Holmberg, S. W., Levy, B., and Sands, M. S. (1998). Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function. J. Clin. Invest. 101, 1394-1400.
62. Peltékian, E., Garcia, L., and Danos, O. (2002). Neurotropism and retrograde axonal transport of a canine adenoviral vector: A tool for targeting key structures undergoing neurodegenerative processes. Mol. Ther. 5, 25-32.
63. Peters, C., Rommerskirch, W., Modaressi, S., and von Figura, K. (1991). Restoration of arylsulphatase B activity in human mucopolysaccharidosis-type-VI fibroblasts by retroviral-vector-mediated gene transfer. Biochem. J. 276, 499-504.
64. Peters, C., Balthazor, M., Shapiro, E. G., King, R. J., Kollman, C., Hegland, J. D., Henslee-Downey, J., Trigg, M. E., Cowan, M. J., Sanders, J., Bunin, N., Weinstein, H., Lenarsky, C., Falk, P., Harris, R., Bowen, T., Williams, T. E., Grayson, G. H., Warkentin, P., Sender, L., Cool, V. A., Crittenden, M., Packman, S., Kaplan, P., Lockman, L. A., et al. (1996). Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87, 4894-1902.
65. Peters, C., Shapiro, E. G., Anderson, J., Henslee-Downey, P. J., Klemperer, M. R., Cowan, M. J., Saunders, E. F., deAlarcon, P. A., Twist, C., Nachman, J. B., Hale, G. A., Harris, R. E., Rozans, M. K., Kurtzberg, J., Grayson, G. H., Williams, T. E., Lenarsky, C., Wagner, J. E., and Krivit, W. (1998). Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 91, 2601-2608.
66. Pfeffer, S. R. (1991). Targeting of proteins to the lysosome. Curr. Top. Microbiol. Immunol. 70, 43-65.
67. Poorthuis, B. J., Romme, A. E., Willemsen, R., and Wagemaker, G. (1994). Bone marrow transplantation has a significant effect on enzyme levels and storage of glycosaminoglycans in tissues and in isolated hepatocytes of mucopolysaccharidosis type VII mice. Pediatr. Res. 36, 187-193.
68. Robbins J. C., Lam, M. H., Tripp, C. S., Bugianesi, R. L., Ponpipom, M. M., and Shen, T. Y. (1981). Synthetic glycopeptide substrates for receptor-mediated endocytosis by macrophages. Proc. Natl. Acad. Sci. USA 78, 7294-7298.
69. Ross, C. J., Ralph, M., and Chang, P. L. (1999). Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsules. Hum. Gene Ther. 10, 49-59.
70. Ross, C. J., Bastedo, L., Maier, S. A., Sands, M. S., and Chang, P. L. (2000a). Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells. Hum. Gene Ther. 11, 2117-2127.
71. Ross, C. J., Ralph, M., and Chang, P. L. (2000b). Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells. Exp. Neurol. 166, 276-286.
72. Salvetti, A., Moullier, P., Cornet, V., Brooks, D., Hopwood, J. J., Danos, O., and Heard, J. M. (1995). In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs. Hum. Gene Ther. 6, 1153-1159.
73. Sando, G. N., and Neufeld, E. F. (1977). Recognition and receptor-mediated uptake of a lysosomal enzyme, alpha-1-iduronidase, by cultured human fibroblasts. Cell 12, 619-627.
74. Sands, M. S., Barker, J. E., Vogler, C., Levy, B., Gwynn, B., Galvin, N., Sly, W. S., and Birkenmeier, E. (1993). Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab. Invest. 68, 676-686.
75. Sands, M. S., Vogler, C., Kyle J. W., Grubb, J. H., Levy, B., Galvin, N., Sly, W. S., and Birkenmeier, E. H. (1994). Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J. Clin. Invest. 93, 2324-2331.
76. Sands, M. S., Erway, L. C., Vogler, C., Sly, W. S., and Birkenmeier, E. H. (1995). Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII. Blood 86, 2033-2040.
77. Schiffmann, R., Murray, G. J., Treco, D., Daniel, P., Sellos-Moura, M., Myers, M., Quirk, J. M., Zirzow, G. C., Borowski, M., Loveday, K., Anderson, T., Gillespie, F., Oliver, K. L., Jeffries, N. O., Doo, E., Liang, T. J., Kreps, C., Gunter, K., Frei, K., Crutchfield, K., Selden, R. F., and Brady, R. O. (2000). Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc. Natl. Acad. Sci. USA 97, 365-370.
78. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F. (1999). In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science 285, 1569-1572.
79. Serguera, C., Sarkis, C., Ridet, J. L., Colin, P., Moullier, P., and Mallet, J. (2001). Primary adult human astrocytes as an ex vivo vehicle for beta-glucuronidase delivery in the brain. Mol. Ther. 3, 875-881.
80. Sferra, T. J., Qu, G., McNeely, D., Rennard, R., Clark, K. R., Lo, W. D., and Johnson, P. R. (2000). Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse. Hum. Gene Ther. 11, 507-519.
81. Shull, R. M., Kakkis, E. D., McEntee, M. E, Kania, S. A., Jonas, A. J., and Neufeld, E. F. (1994). Enzyme replacement in a canine model of Hurler syndrome. Proc. Natl. Acad. Sci. USA 91, 12937-12941.
82. Skorupa, A. F., Fisher, K. J., Wilson, J. M., Parente, M. K., and Wolfe, J. H. (1999). Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp. Neurol. 160, 17-27.
83. Slavin, S., and Yatziv, S. (1980). Correction of enzyme deficiency in mice by allogeneic bone marrow transplantation with total lymphoid irradiation. Science 210, 1150-1152.
84. Sly, W. S., Vogler, C., Grubb, J. H., Zhou, M., Jiang, J., Zhou, X. Y., Tomatsu, S., Bi, Y., and Snella, E. M. (2001). Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice. Proc. Natl. Acad. Sci. USA 98, 2205-2210.
85. Snyder, E. Y., Taylor, R. M., and Wolfe, J. H. (1995). Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374, 367-370.
86. Soper, B. W., Lessard, M. D., Vogler, C. A., Levy, B., Beamer, W. G., Sly, W. S., and Barker, J. E. (2001). Nonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiency. Blood 97, 1498-1504.
87. Spellacy, E., Shull, R. M., Constantopoulos, G., and Neufeld, E. F. (1983). A canine model of human alpha-L-iduronidase deficiency. Proc. Natl. Acad. Sci. USA 80, 6091-6095.
88. Stein, C. S., Ghodsi, A., Derksen, T., and Davidson, B. L. (1999). Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII mice. J. Virol. 73, 3424-3429.
89. Stein, C. S., Kang, Y., Sauter, S. L., Townsend, K., Staber, P., Derksen, T. A., Martins, I., Qian, J., Davidson, B. L., and McCray, P. B., Jr. (2001). In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Mol. Ther. 3, 850-856.
90. Taylor, R. M., and Wolfe, J. H. (1997). Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase. Nat. Med. 3, 771-774.
91. Thompson, J. N., Jones, M. Z., Dawson, G., and Huffman, P. S. (1992). N-Acetylglucosamine 6-sulphatase deficiency in a Nubian goat: A model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID). J. Inherit. Metab. Dis. 15, 760-768.
92. Van den Hout, H., Reuser, A. J., Vulto, A. G., Loonen, M. C., Cromme-Dijkhuis, A., and Van der Ploeg, A. T. (2000). Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 356, 397-398.
93. Vogler, C., Sands, M. S., Levy, B., Galvin, N., Birkcnmeier, E. H., and Sly, W. S. (1996). Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: Impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival. Pediatr. Res. 39, 1050-1054.
94. Vogler, C., Levy, B., Galvin, N. J., Thorpe, C., Sands, M. S., Barker, J. E., Baty, J., Birkenmeier, E. H., and Sly, W. S. (1999). Enzyme replacement in murine mucopolysaccharidosis type VII: Neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy. Pediatr. Res. 45, 838-844.
95. Watson, G. L., Sayles, J. N., Chen, C., Elliger, S. S., Elliger, C. A., Raju, N. R., Kurtzman, G. J., and Podsakoff, G. M. (1998). Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus. Gene Ther. 5, 1642-1649.
96. Whitley, C. B., Belani, K. G., Chang, P. N., Summers, C. G., Blazar, B. R., Tsai, M. Y., Latchaw, R. E., Ramsay, N. K., and Kersey, J. H. (1993). Long-term outcome of Hurler syndrome following bone marrow transplantation. Am. J. Med. Genet. 46, 209-218.
97. Wilkerson, M. J., Lewis, D. C., Marks, S. L., and Prieur, D. J. (1998). Clinical and morphologic features of mucopolysaccharidosis type II in a dog: naturally occurring model of Hunter syndrome. Vet. Pathol. 35, 230-233.
98. Wolfe, J. H., Schuchman, E. H., Stramm, L. E., Concaugh, E. A., Haskins, M. E., Aguirre, G. D., Patterson, D. F., Desnick, R. J., and Gilboa, E. (1990). Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer. Proc. Natl. Acad. Sci. USA 87, 2877-2881.
99. Wolfe, J. H., Sands, M. S., Barker, J. E., Gwynn, B., Rowe, L. B., Vogler, C. A., and Birkenmeier, E. H. (1992). Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature 360, 749-753.
100. Wolfe, J. H., Martin, C. E., Deshmane, S. L., Reilly, J. J., Kesari, S., and Fraser, N. W. (1996). Increased susceptibility to the pathogenic effects of wild-type and recombinant herpesviruses in MPS VII mice compared to normal siblings. J. Neurovirol. 2, 417-422.
101. Wolfe, J. H., Sands, M. S., Harel, N., Weil, M. A., Parente, M. K., Polesky, A. C., Reilly, J. J., Hasson, C., Weimelt, S., and Haskins, M. E. (2000). Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII. Mol. Ther. 2, 552-561.
102. Xia, H., Mao, Q., and Davidson, B. L. (2001). The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Nat. Biotechnol. 19, 640-644.
103. Xu, L, Haskins, M. E., Melniczek, J. R., Gao, C., Weil, M. A., O'Malley, T. M., O'Donnell, P. A., Mazrier, H., Ellinwood, N. M., Zweigle, J., Wolfe, J. H., and Ponder, K. P. (2002). Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs. Mol. Ther. 5, 141-153.
104. Yatziv, S., Weiss, L., Morecki, S., Fuks, Z., and Slavin, S. (1982). Long-term enzyme replacement therapy in beta-glucuronidase-defficient mice by allogeneic bone marrow transplantation. J. Lab. Clin. Med. 99, 792-797.
105. Yoshida, M., Noguchi, J., Ikadai, H., Takahashi, M., and Nagase, S. (1993). Arylsulfatase B-deficient mucopolysaccharidosis in rats. J. Clin. Invest. 91, 1099-1104.
106. Yu, W. H., Zhao, K. W., Ryazantsev, S., Rozengurt, N., and Neufeld, E. F. (2000). Short-term enzyme replacement in the murine model of Sanfilippo syndrome type B. Mol. Genet. Metab. 71, 573-580.
107. Zhu, J., Kang, W., Wolfe, J. H., and Fraser, N. W. (2000). Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector. Mol. Ther. 2, 82-94.